[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-295519-105":59,"doc-detail-295519-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","canadian-adhd-practice-guidelines-edition-41-january-6-2021","Canadian ADHD Practice Guidelines - Edition 4.1 - January 6, 2021","","Copyright notice and permitted-use terms for the Canadian ADHD Practice Guidelines, including restrictions on copying, redistribution, and noncommercial presentation. Provides contact and ordering information for CADDRA (Canadian ADHD Resource Alliance), the required citation format, availability of a French edition title, feedback channels, liability limitations, and guidance to consult prescribing information. Includes edition identification (4.1), publication/citation details, ISBN, and a detailed table of contents covering ADHD diagnosis and comorbid differential diagnoses.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/canadian-adhd-practice-guidelines-edition-41-january-6-2021/295519/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/canadian-adhd-practice-guidelines-edition-41-january-6-2021/295519.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-18",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",27,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are the permitted uses for the Canadian ADHD Practice Guidelines materials?","Question",{"text":113,"@type":114},"You may download one copy for personal or medical practice use and reproduce specific tools/handouts when developed for medical professionals. You may also give a noncommercial presentation for public education while keeping copyright notices intact.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Can the materials be modified or used for other purposes without permission?",{"text":118,"@type":114},"No. Modifying the materials or using them for other purposes without prior written consent from CADDRA violates CADDRA's copyright and proprietary rights.",{"name":120,"@type":111,"acceptedAnswer":121},"What guidance is provided regarding liability and prescribing decisions?",{"text":122,"@type":114},"The document disclaims liability for errors or consequences arising from use. It also notes it is not intended to replace prescribing information, urging physicians to consult the manufacturer’s product monograph and related drug information before prescribing.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},295519,1789719600,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":130,"read_time":145},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Copyright Notice and Permitted Uses of the Guidelines  \nNo material available at [www.caddra.ca](www.caddra.ca) (the \"Materials\") may be copied, reproduced, republished, uploaded, posted, transmitted, or distributed in any way, except that you may:  \n(a) Download one copy of the Materials on any single computer for your personal or medical practice use only, provided you keep intact all copyright and other proprietary notices. Where stipulated, specific “tools and patient handouts”, developed for physicians and other medical professionals to use in their practice, may be reproduced by medical professionals or on the advice of medical professionals;(b) Give a presentation using the Materials, so long as: (i) the purpose of the presentation or distribution is for public education; (ii) you keep intact all copyright and other proprietary notices in the Materials; and (iii) the presentation or distribution is completely noncommercial and you or your organization receive no monetary compensation . If monetary compensation is involved, you must provide notice to CADDRA at least ten (10) business days before the presentation and request permission.  \nModification of the Materials or use of the Materials for any other purpose, without the prior written consent of CADDRA, is a violation of CADDRA's copyright and other proprietary rights.  \nCADDRA Information  \nCurrent contact details for CADDRA-Canadian ADHD Resource Alliance and information on ordering copies of the Canadian ADHD Practice Guidelines are available on the CADDRA website: [www.caddra.ca](www.caddra.ca)  \nGuidelines Citation  \nThe correct citation for this document is: CADDRA-Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.  \nFrench Edition  \nThis document is available in French under the title: Lignes Directrices Canadiennes pour le TDAH, 4.1 Édition.  \nFeedback  \nReader suggestions can be provided through our website ([www.caddra.ca](www.caddra.ca)) or by emailing info@caddra.ca.  \nLiability  \nWhile great effort has been taken to ensure the accuracy of the information, the Guidelines Committee, CADDRA and its members, designer, printer and others contributing to the preparation of this document cannot accept liability for errors, omissions or any consequences arising from the use of the information. Since this document is not intended to replace other prescribing information, physicians are urged to consult the manufacturer’s product monograph and other available drug information literature before prescribing.  \nPlease Note:  \nThe CADDRA website ([www.caddra.ca](www.caddra.ca)) will always have the latest version of the Guidelines available free to download and print.  \nISBN: 978-0-9738168-7-7  \n© CADDRA-2020 Canadian ADHD Resource Alliance  \nTABLE OF CONTENTS  \nINDEX OF TABLES AND FIGURES / USB CONTENTS.................................................................................................... i  \nGUIDELINES EDITORS AND CONTRIBUTORS............................................................................................................ ii  \nPREFACE............................................................................................................................................................. 1  \nCHAPTER 1: DIAGNOSIS OF ADHD ......................................................................................................................... 3  \nCHAPTER 2: DIFFERENTIAL DIAGNOSIS AND COMORBID DISORDERS....................................................................... 14  \nPREVALENCE OF COMORBIDITIES .................................................................................................................................. 14  \nOPPOSITIONAL DEFIANT DISORDER ............................................................................................................................... 16  \nCONDUCT DISORDER/AGGRESSION .................................................................","cbCaitb2RfSsDGN1","https://ap.wps.com/l/cbCaitb2RfSsDGN1","pdf",4288598,122,"English","# Preface\n# Chapter 1: Diagnosis of ADHD\n# Chapter 2: Differential Diagnosis and Comorbid Disorders\n## Prevalence of Comorbidities\n## Oppositional Defiant Disorder\n## Conduct Disorder/Aggression\n## Antisocial Personality Disorder\n## Borderline Personality Disorder\n## Addictions\n## Substance Use Disorder\n## Anxiety Disorder\n## Major Depressive Disorder\n## Bipolar Disorder\n## Disruptive Mood Dysregulation Disorder\n## Obsessive-Compulsive Disorder\n## Tourette Syndrome and Tic Disorders\n## Eating Disorders\n## Autism Spectrum Disorder","[{\"question\":\"What are the permitted uses for the Canadian ADHD Practice Guidelines materials?\",\"answer\":\"You may download one copy for personal or medical practice use and reproduce specific tools/handouts when developed for medical professionals. You may also give a noncommercial presentation for public education while keeping copyright notices intact.\"},{\"question\":\"Can the materials be modified or used for other purposes without permission?\",\"answer\":\"No. Modifying the materials or using them for other purposes without prior written consent from CADDRA violates CADDRA's copyright and proprietary rights.\"},{\"question\":\"What guidance is provided regarding liability and prescribing decisions?\",\"answer\":\"The document disclaims liability for errors or consequences arising from use. It also notes it is not intended to replace prescribing information, urging physicians to consult the manufacturer’s product monograph and related drug information before prescribing.\"}]","Canadian ADHD Practice Guidelines - Edition 4.1 - January 6, 2021 | PDF",307]